2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Leukemia, Myeloid, Acute
311
Leukemia, Lymphocytic, Chronic, B-Cell
108
Myelodysplastic Syndromes
63
Recurrence
55
Leukemia
43
Neoplasms
42
Precursor Cell Lymphoblastic Leukemia-Lymphoma
41
Lymphoma, Non-Hodgkin
41
Lymphoma, Mantle-Cell
32
Multiple Myeloma
28
Lymphoma, Large B-Cell, Diffuse
27
Leukemia, Myelomonocytic, Chronic
27
Lymphoma, Follicular
22
Lymphoma
21
Hematologic Neoplasms
20
Lymphoma, B-Cell, Marginal Zone
18
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
17
Leukemia, Biphenotypic, Acute
16
Burkitt Lymphoma
16
Myeloproliferative Disorders
11
Lymphoma, B-Cell
11
Leukemia, Myeloid
11
Neoplasm, Residual
10
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
10
Waldenstrom Macroglobulinemia
9
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
7
Chromosome 17 deletion
6
Leukemia, B-Cell
5
Immunoglobulin Light-chain Amyloidosis
5
Breast Neoplasms
5
Interventions
Cyclophosphamide
64
Tacrolimus
55
Methotrexate
46
Mycophenolic Acid
39
Cyclosporine
37
fludarabine phosphate
35
Busulfan
35
Antilymphocyte Serum
32
fludarabine
29
Sirolimus
26
Melphalan
23
Peripheral Blood Stem Cell Transplantation
22
Radiotherapy
21
Methylprednisolone
21
Whole-Body Irradiation
19
Filgrastim
17
thymoglobulin
14
Thiotepa
11
Stem Cell Transplantation
10
Rituximab
10
ruxolitinib
9
Granulocyte Colony-Stimulating Factor
9
Prednisone
7
Hematopoietic Stem Cell Transplantation
7
Etoposide
7
Cord Blood Stem Cell Transplantation
7
Alemtuzumab
7
Transplantation
6
Pentostatin
6
Cytarabine
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Graft vs Host Disease
×
venetoclax
×
Clear all
NCT05005299
2023-08-01
VICTORY
Melbourne Health
Phase 1
Unknown
18 enrolled